PDL BioPharma (PDLI) Reports Mixed Q3 Results; Narrows FY09 Sales Guidance
Tweet Send to a Friend
PDL BioPharma, Inc. (Nasdaq: PDLI) reports Q3 EPS of $0.29, 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
